Cancer Immunology, Immunotherapy Issues Research Articles in May 2023 Edition
April 18, 2023
April 18, 2023
BASEL, Switzerland, April 18 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its May 2023 edition:
Reviews:
* Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis
Research:
* Local immunotherapy with the RNA-based immune stimulator C . . .
Reviews:
* Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis
Research:
* Local immunotherapy with the RNA-based immune stimulator C . . .